Acinetobacter baumannii Infection in Transfusion Dependent Thalassemia Patients with Sepsis
- PMID: 28596960
- PMCID: PMC5450173
- DOI: 10.1155/2017/2351037
Acinetobacter baumannii Infection in Transfusion Dependent Thalassemia Patients with Sepsis
Abstract
Purpose: To identify the Acinetobacter baumannii infection among transfusion dependent thalassemia patients.
Methods: A quantitative approach was employed to assess Acinetobacter baumannii infection in transfusion dependent thalassemia patients. Samples were collected from 916 patients, which have shown bacterial growth on MacConkey and blood agar culture media. A. baumannii strains were identified by microbiological methods and Gram's staining. API 20 E kit (Biomerieux, USA) was used for final identification.
Results: From 916 cultured blood specimens, 107 (11.6%) showed growth of A. baumannii. Serum ferritin in thalassemic patients without bacterial infections was 3849.5 ± 1513.5 µg/L versus 6413.5 ± 2103.9 µg/L in those with bacterial infections (p = 0.0001). Acinetobacter baumannii infected patients have shown higher serum ferritin levels (p = 0.0001). Serum ferritin in thalassemic patients was 3849.5 ± 1513.5 µg/L versus 6413.5 ± 2103.9 µg/L in those with bacterial infections (p = 0.0001). Acinetobacter baumannii infected patients showed high serum ferritin levels (p = 0.0001). The clinical symptoms have been found with A. baumannii +ve with a mean and standard deviation of 47 (5.1%) and A. baumannii -ve with mean and standard deviation of 60 (6.5%).
Conclusion: Isolation of asymptomatic A. baumannii from the thalassemia patients shows an alarming situation of bacterial infections. A continuous surveillance of transfusion dependent thalassemia patients is recommended for bacterial sepsis.
Conflict of interest statement
The authors declare that there are no conflicts of interest regarding the publication of this paper.
Similar articles
-
Current Trends of Drug Resistance Patterns of Acinetobacter baumannii Infection in Blood Transfusion-dependent Thalassemia Patients.J Glob Infect Dis. 2017 Oct-Dec;9(4):135-138. doi: 10.4103/jgid.jgid_151_16. J Glob Infect Dis. 2017. PMID: 29302147 Free PMC article.
-
[Risk factors and resistance patterns of invasive Acinetobacter Baumannii infection in Children].Zhonghua Er Ke Za Zhi. 2022 Aug 2;60(8):762-768. doi: 10.3760/cma.j.cn112140-20220502-00404. Zhonghua Er Ke Za Zhi. 2022. PMID: 35922185 Chinese.
-
Risk factors and outcomes of bloodstream infections caused by Acinetobacter baumannii: a case-control study.Diagn Microbiol Infect Dis. 2021 Feb;99(2):115229. doi: 10.1016/j.diagmicrobio.2020.115229. Epub 2020 Sep 30. Diagn Microbiol Infect Dis. 2021. PMID: 33161239
-
Analysis of clinical and microbiological data on Acinetobacter baumannii strains assist the preauthorization of antibiotics at the patient level for an effective antibiotic stewardship program.J Infect Public Health. 2017 Sep-Oct;10(5):608-616. doi: 10.1016/j.jiph.2017.01.014. Epub 2017 Feb 23. J Infect Public Health. 2017. PMID: 28237694
-
[Acinetobacter baumannii bacteremia].Rev Med Inst Mex Seguro Soc. 2010 Nov-Dec;48(6):625-34. Rev Med Inst Mex Seguro Soc. 2010. PMID: 21184718 Review. Spanish.
Cited by
-
Ferritin in pediatric critical illness: a scoping review.Clin Exp Pediatr. 2023 Mar;66(3):98-109. doi: 10.3345/cep.2022.00654. Epub 2022 Sep 16. Clin Exp Pediatr. 2023. PMID: 36229027 Free PMC article.
-
Antimicrobial peptide 2K4L disrupts the membrane of multidrug-resistant Acinetobacter baumannii and protects mice against sepsis.Front Microbiol. 2023 Oct 24;14:1258469. doi: 10.3389/fmicb.2023.1258469. eCollection 2023. Front Microbiol. 2023. PMID: 37942076 Free PMC article.
-
Infections in G6PD-Deficient Hospitalized Patients-Prevalence, Risk Factors, and Related Mortality.Antibiotics (Basel). 2022 Jul 12;11(7):934. doi: 10.3390/antibiotics11070934. Antibiotics (Basel). 2022. PMID: 35884188 Free PMC article.
-
Construction and Validation of a Predictive Model for Mortality Risk in Patients with Acinetobacter baumannii Bloodstream Infection.Infect Drug Resist. 2024 Nov 26;17:5247-5260. doi: 10.2147/IDR.S491537. eCollection 2024. Infect Drug Resist. 2024. PMID: 39624638 Free PMC article.
-
Antimicrobial peptide 2K4L inhibits the inflammatory response in macrophages and Caenorhabditis elegans and protects against LPS-induced septic shock in mice.Sci Rep. 2024 Jul 2;14(1):15093. doi: 10.1038/s41598-024-64511-9. Sci Rep. 2024. PMID: 38956179 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical